FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983384893> ?p ?o ?g. }

• W1983384893 endingPage "487" @default.
• W1983384893 startingPage "481" @default.
• W1983384893 abstract "The α(ν)β(3) integrin is over-expressed in the tumor neovasculature and the tumor cells of glioblastomas. The HIV Tat-derived peptide has been used to deliver various cargos into cells. The aim of this research was to synthesize and assess the in vitro and in vivo uptake of 99mTc-N2S2-Tat(49–57)-c(RGDyK) (99mTc-Tat-RGD) in α(ν)β(3) integrin positive cancer cells and compare it to that of a conventional 99mTc-RGD peptide (99mTc-EDDA/HYNIC-E-[c(RGDfK)]2). Methods: The c(RGDyK) peptide was conjugated to a maleimidopropionyl (MP) moiety through Lys, and the MP group was used as the branch position to form a thioether with the Cys12 side chain of the Tat(49–57)-spacer-N2S2 peptide. 99mTc-Tat-RGD was prepared, and stability studies were carried out by size exclusion HPLC analyses in human serum. The in vitro affinity for α(v)β(3) integrin was determined by a competitive binding assay. In vitro internalization was determined using glioblastoma C6 cells. Biodistribution studies were accomplished in athymic mice with C6 induced tumors that had blocked and unblocked receptors. Images were obtained using a micro-SPECT/CT. Results: 99mTc-Tat-RGD was obtained with a radiochemical purity higher than 95%, as determined by radio-HPLC and ITLC-SG analyses. Protein binding was 15.7% for 99mTc-Tat-RGD and 5.6% for 99mTc-RGD. The IC50 values were 6.7 nM (99mTc-Tat-RGD) and 4.6 nM (99mTc-RGD). Internalization in C6 cells was higher in 99mTc-Tat-RGD (37.5%) than in 99mTc-RGD (10%). Biodistribution studies and in vivo micro-SPECT/CT images in mice showed higher tumor uptake for 99mTc-Tat-RGD (6.98% ± 1.34% ID/g at 3 h) than that of 99mTc-RGD (3.72% ± 0.52% ID/g at 3 h) with specific recognition for α(v)β(3) integrins. Conclusions: Because of the significant cell internalization (Auger and internal conversion electrons) and specific recognition for α(v)β(3) integrins, the hybrid 99mTc-N2S2-Tat(49–57)-c(RGDyK) radiopharmaceutical is potentially useful for the imaging and possible therapy of tumors expressing α(v)β(3) integrins." @default.
• W1983384893 created "2016-06-24" @default.
• W1983384893 creator A5000294204 @default.
• W1983384893 creator A5002855256 @default.
• W1983384893 creator A5013297189 @default.
• W1983384893 creator A5034039844 @default.
• W1983384893 creator A5039345261 @default.
• W1983384893 creator A5040251027 @default.
• W1983384893 creator A5045985378 @default.
• W1983384893 creator A5052574925 @default.
• W1983384893 creator A5084871018 @default.
• W1983384893 date "2013-05-01" @default.
• W1983384893 modified "2023-10-18" @default.
• W1983384893 title "Design and biological evaluation of 99mTc-N2S2-Tat(49–57)-c(RGDyK): A hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins" @default.
• W1983384893 cites W1967626755 @default.
• W1983384893 cites W1972936061 @default.
• W1983384893 cites W1979750883 @default.
• W1983384893 cites W1981794898 @default.
• W1983384893 cites W1983200534 @default.
• W1983384893 cites W1985164165 @default.
• W1983384893 cites W2000799481 @default.
• W1983384893 cites W2005955558 @default.
• W1983384893 cites W2013816395 @default.
• W1983384893 cites W2015476325 @default.
• W1983384893 cites W2020015356 @default.
• W1983384893 cites W2035024378 @default.
• W1983384893 cites W2049067964 @default.
• W1983384893 cites W2064402168 @default.
• W1983384893 cites W2078627327 @default.
• W1983384893 cites W2085886295 @default.
• W1983384893 cites W2086200886 @default.
• W1983384893 cites W2091814385 @default.
• W1983384893 cites W2101281436 @default.
• W1983384893 cites W2128302079 @default.
• W1983384893 cites W2145270911 @default.
• W1983384893 doi "https://doi.org/10.1016/j.nucmedbio.2013.01.003" @default.
• W1983384893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23618768" @default.
• W1983384893 hasPublicationYear "2013" @default.
• W1983384893 type Work @default.
• W1983384893 sameAs 1983384893 @default.
• W1983384893 citedByCount "12" @default.
• W1983384893 countsByYear W19833848932014 @default.
• W1983384893 countsByYear W19833848932015 @default.
• W1983384893 countsByYear W19833848932016 @default.
• W1983384893 countsByYear W19833848932017 @default.
• W1983384893 countsByYear W19833848932018 @default.
• W1983384893 countsByYear W19833848932019 @default.
• W1983384893 countsByYear W19833848932020 @default.
• W1983384893 countsByYear W19833848932022 @default.
• W1983384893 crossrefType "journal-article" @default.
• W1983384893 hasAuthorship W1983384893A5000294204 @default.
• W1983384893 hasAuthorship W1983384893A5002855256 @default.
• W1983384893 hasAuthorship W1983384893A5013297189 @default.
• W1983384893 hasAuthorship W1983384893A5034039844 @default.
• W1983384893 hasAuthorship W1983384893A5039345261 @default.
• W1983384893 hasAuthorship W1983384893A5040251027 @default.
• W1983384893 hasAuthorship W1983384893A5045985378 @default.
• W1983384893 hasAuthorship W1983384893A5052574925 @default.
• W1983384893 hasAuthorship W1983384893A5084871018 @default.
• W1983384893 hasConcept C112613896 @default.
• W1983384893 hasConcept C139770010 @default.
• W1983384893 hasConcept C150903083 @default.
• W1983384893 hasConcept C153911025 @default.
• W1983384893 hasConcept C170493617 @default.
• W1983384893 hasConcept C178790620 @default.
• W1983384893 hasConcept C185592680 @default.
• W1983384893 hasConcept C195687474 @default.
• W1983384893 hasConcept C202751555 @default.
• W1983384893 hasConcept C207001950 @default.
• W1983384893 hasConcept C2776568683 @default.
• W1983384893 hasConcept C2777807558 @default.
• W1983384893 hasConcept C2779281246 @default.
• W1983384893 hasConcept C521977710 @default.
• W1983384893 hasConcept C55493867 @default.
• W1983384893 hasConcept C71240020 @default.
• W1983384893 hasConcept C86803240 @default.
• W1983384893 hasConceptScore W1983384893C112613896 @default.
• W1983384893 hasConceptScore W1983384893C139770010 @default.
• W1983384893 hasConceptScore W1983384893C150903083 @default.
• W1983384893 hasConceptScore W1983384893C153911025 @default.
• W1983384893 hasConceptScore W1983384893C170493617 @default.
• W1983384893 hasConceptScore W1983384893C178790620 @default.
• W1983384893 hasConceptScore W1983384893C185592680 @default.
• W1983384893 hasConceptScore W1983384893C195687474 @default.
• W1983384893 hasConceptScore W1983384893C202751555 @default.
• W1983384893 hasConceptScore W1983384893C207001950 @default.
• W1983384893 hasConceptScore W1983384893C2776568683 @default.
• W1983384893 hasConceptScore W1983384893C2777807558 @default.
• W1983384893 hasConceptScore W1983384893C2779281246 @default.
• W1983384893 hasConceptScore W1983384893C521977710 @default.
• W1983384893 hasConceptScore W1983384893C55493867 @default.
• W1983384893 hasConceptScore W1983384893C71240020 @default.
• W1983384893 hasConceptScore W1983384893C86803240 @default.
• W1983384893 hasIssue "4" @default.
• W1983384893 hasLocation W19833848931 @default.
• W1983384893 hasLocation W19833848932 @default.
• W1983384893 hasOpenAccess W1983384893 @default.
• W1983384893 hasPrimaryLocation W19833848931 @default.

• next